Laminomics develops the Shepherd System, which utilizes genetic data to create personalized pharmaceutical recommendations for space travelers, addressing the health risks associated with prolonged exposure to space environments. Additionally, the company is constructing LAM City, a self-sustaining Antarctic settlement that simulates extraterrestrial conditions to test survival strategies and health innovations for future interplanetary habitation.
Funding
Funding not disclosed
Founders
Product
Problem
Prolonged exposure to space environments poses significant health risks to space travelers, as the human body is biologically unprepared for such conditions. A large percentage of astronauts experience illness after relatively short periods in space, highlighting the need for countermeasures.
Solution
Laminomics is developing the Shepherd System, a health technology that leverages individual biodata to create personalized pharmaceutical products designed to protect and adapt individuals to the biohazards of space travel and extreme environments. The system provides individuals with tailored health insights, while also offering key stakeholders access to extensive biological datasets. Laminomics is also constructing LAM City, a self-sufficient Antarctic city-state, to simulate extraterrestrial conditions and test survival strategies, economic models, and health innovations crucial for future interplanetary settlement.
Target Audience
The primary target audience includes space travelers, researchers, medical practitioners, and companies involved in space exploration and extreme environment adaptation.
Features
- Personalized pharmaceutical recommendations based on individual genetic data
- Biodata utilization for targeted drug development
- Simulation of extraterrestrial conditions in a self-sufficient Antarctic city-state
- Testing of survival strategies and health innovations for space exploration
- Development of economic models for sustainable space settlements